CALIFORNIA CAPITAL EQUITY, LLC
SEC CIK 1517764 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | 10% | 29.76M | — | — | 3 | 2024-12-10 | 2026-02-22 |
Most active insiders at IBRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Simon Barry J. | Dir | — | $4.14M |
| 2 | Selecky Christobel | Dir | — | $3.00M |
| 3 | Cohen Cheryl | Dir | — | $1.25M |
| 4 | Sachs David C. | CFO | — | — |
| 5 | Adcock Richard | CEO, Pres, Dir | — | — |
| 6 | CALIFORNIA CAPITAL EQUITY, LLC | 10% | — | — |
| 7 | LAUER REGAN J | CAO | — | — |
| 8 | SOON-SHIONG PATRICK | See remarks, Dir, 10% | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-24 | 2026-02-22 | IBRX | ImmunityBio, Inc. | CALIFORNIA CAPITAL EQUITY, LLC | 10% | F - Tax | $8.70 | -58.2K | 29.76M | -0.2% | -$506.1K |
| D | 2026-02-24 | 2026-02-22 | IBRX | ImmunityBio, Inc. | CALIFORNIA CAPITAL EQUITY, LLC | 10% | M - OptEx | $0.00 | +114.3K | 29.82M | +0.4% | $0 |
| DMI | 2024-12-12 | 2024-12-10 | IBRX | ImmunityBio, Inc. | CALIFORNIA CAPITAL EQUITY, LLC | 10% | C - Cnv Deriv | $1.98 | +117.19M | 246.41M | +91% | +$231.92M |
Purchase Sale Sale after option exercise All abbreviations